Patient Resources

1. Home
2. Patient Resources
3. Health Videos

Get Healthy!

Health News Videos

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

• June 23, 2025
• HealthDayTV HealthDay Reporter

In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.

HeadachesMigraine

Health News is provided as a service to Sav-Mor Drugs site users by HealthDay. Sav-Mor Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2026 HealthDay All Rights Reserved.

Share

---

Tags

HeadachesMigraine